Camlin Fine Sciences マネジメント
マネジメント 基準チェック /34
現在、CEO に関する十分な情報がありません。
主要情報
Ashish Dandekar
最高経営責任者
₹28.2m
報酬総額
| CEO給与比率 | 54.61% |
| CEO在任期間 | 19.3yrs |
| CEOの所有権 | 10.3% |
| 経営陣の平均在職期間 | 4.7yrs |
| 取締役会の平均在任期間 | 5.7yrs |
経営陣の近況
Recent updates
ナラティブの更新 • Apr 26
532834: Upcoming Meetings Will Support Bullish Outlook With Stable Forward Assumptions
Analysts have left the Camlin Fine Sciences price target unchanged at ₹182.5, explaining that a slightly lower discount rate and marginally higher profit margin assumptions are balanced by a modestly lower future P/E input. What's in the News Special and Extraordinary Shareholders Meeting scheduled via postal ballot in India on May 7, 2026, indicating upcoming shareholder decisions that may affect the company structure or capital plans (Key Developments).ナラティブの更新 • Apr 11
532834: Upcoming Meetings Will Support Confident Outlook Despite Revised Forecast Assumptions
Analysts have trimmed their price target on Camlin Fine Sciences from ₹235 to ₹182.5. This reflects updated assumptions around fair value, revenue growth, profit margins and future P/E expectations. What's in the News Board meeting scheduled for Feb 13, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).ナラティブの更新 • Mar 25
532834: Upcoming Results Meeting Will Reinforce Steady Assumptions Supporting Upside Potential
Analysts have kept the fair value estimate for Camlin Fine Sciences steady at ₹235, with only minor tweaks to assumptions on discount rate, revenue growth, profit margin and future P/E, resulting in a largely unchanged price target narrative. What's in the News Board meeting scheduled on February 13, 2026 to consider and approve the unaudited standalone financial results for the quarter and nine months ended December 31, 2025 (company filing).ナラティブの更新 • Mar 10
532834: Scheduled Results Review Will Confirm Steady Assumptions Supporting Upside Potential
Analysts have kept their fair value estimate for Camlin Fine Sciences steady at ₹235, citing largely unchanged assumptions around revenue growth, profit margins and future P/E, with only minor tweaks to the discount rate and valuation inputs. What's in the News Board meeting scheduled for February 13, 2026, to review and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (company filing).ナラティブの更新 • Feb 24
532834: Upcoming Results Review Will Support Long Term Upside Potential
Analysts have adjusted their fair value estimate for Camlin Fine Sciences from ₹240 to ₹235, reflecting updated views on the discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News A board meeting is scheduled for February 13, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (company filing).ナラティブの更新 • Feb 09
532834: Upcoming Board And Director Decisions Will Support Long Term Upside
Analysts have maintained their fair value estimate for Camlin Fine Sciences at ₹240.00, with the small adjustments in discount rate and future P/E assumptions reflecting updated views on risk and valuation drivers rather than a change in the headline price target. What's in the News Board meeting scheduled for February 13, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Key Developments).ナラティブの更新 • Jan 25
532834: Director Reappointment And Steady Assumptions Will Support Long Term Upside
Analysts have kept their fair value estimate for Camlin Fine Sciences steady at ₹240.0 per share, with the unchanged target reflecting consistent assumptions on revenue growth, profit margin and future P/E, alongside a slightly updated discount rate input. What's in the News A board meeting is scheduled for Nov 10, 2025, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended Sep 30, 2025, and to discuss other matters (Key Developments).ナラティブの更新 • Jan 11
532834: Governance Continuity And Stable Assumptions Will Support Long Term Upside
Analysts have kept their price target for Camlin Fine Sciences steady at ₹240.00. This reflects updated assumptions around a slightly higher discount rate and fine-tuned estimates for revenue growth, profit margin and future P/E, without a clear tilt in either a more optimistic or more cautious direction.ナラティブの更新 • Dec 24
532834: Share Swap And Governance Stability Will Drive Long Term Returns
Analysts have maintained their price target for Camlin Fine Sciences at ₹240.00, with only marginal tweaks to the underlying model inputs. This reflects steady confidence in the company’s growth and profitability trajectory.ナラティブの更新 • Dec 10
532834: Share Swap Acquisition Will Drive Long Term Returns
Analysts have modestly maintained their outlook on Camlin Fine Sciences, keeping the price target broadly unchanged near ₹240, as small tweaks to the discount rate and forward earnings assumptions continue to support a steady long term growth narrative. What's in the News Board meeting scheduled for November 10, 2025, to approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025, and to consider the reappointment of Mahabaleshwar Palekar as a non executive independent director (Key Developments).ナラティブの更新 • Nov 26
532834: Share Swap Acquisition And Margin Expansion Will Drive Future Returns
Analysts have lowered their price target for Camlin Fine Sciences from ₹270 to ₹240. They cite updated estimates that reflect improved profit margins and revenue growth, along with a reduced valuation multiple.ナラティブの更新 • Nov 11
532834: Acquisition Plan Will Drive Shareholder Value Despite Margin Pressure
Analysts have revised their price target for Camlin Fine Sciences downward from ₹295 to ₹270. They cited lower expected profit margins, even though revenue growth is projected to be stronger.新しいナラティブ • Sep 04
Tariff Benefits And Safety Trends Will Boost US And Europe
Key Takeaways Plant restarts and easing exceptional expenses are set to improve margins, with structural growth driven by global demand for compliant, high-quality food additives. Favorable trade barriers and China+1 supply diversification position Camlin Fine Sciences for market share gains, margin expansion, and reduced dependence on legacy products.CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Dec 31 2025 | n/a | n/a | -₹141m |
| Sep 30 2025 | n/a | n/a | ₹187m |
| Jun 30 2025 | n/a | n/a | ₹825m |
| Mar 31 2025 | ₹28m | ₹15m | ₹685m |
| Dec 31 2024 | n/a | n/a | -₹2b |
| Sep 30 2024 | n/a | n/a | -₹2b |
| Jun 30 2024 | n/a | n/a | -₹1b |
| Mar 31 2024 | ₹29m | ₹15m | ₹651m |
| Dec 31 2023 | n/a | n/a | -₹8m |
| Sep 30 2023 | n/a | n/a | ₹350m |
| Jun 30 2023 | n/a | n/a | ₹674m |
| Mar 31 2023 | ₹26m | ₹14m | ₹577m |
| Dec 31 2022 | n/a | n/a | ₹581m |
| Sep 30 2022 | n/a | n/a | ₹628m |
| Jun 30 2022 | n/a | n/a | ₹442m |
| Mar 31 2022 | ₹20m | ₹12m | ₹650m |
| Dec 31 2021 | n/a | n/a | ₹598m |
| Sep 30 2021 | n/a | n/a | ₹465m |
| Jun 30 2021 | n/a | n/a | ₹579m |
| Mar 31 2021 | ₹18m | ₹11m | ₹510m |
| Dec 31 2020 | n/a | n/a | ₹394m |
| Sep 30 2020 | n/a | n/a | ₹291m |
| Jun 30 2020 | n/a | n/a | ₹302m |
| Mar 31 2020 | ₹18m | ₹11m | ₹303m |
報酬と市場: Ashishの 総報酬 ($USD 293.70K ) は、 Indian市場 ($USD 174.21K ) の同規模の企業の平均を上回っています。
報酬と収益: Ashishの報酬は、過去 1 年間の会社の業績と一致しています。
CEO
Ashish Dandekar (61 yo)
19.3yrs
在職期間
₹28,216,000
報酬
Mr. Ashish Subhash Dandekar serves as the Chairman of Board at Camlin Fine Sciences Limited since June 17, 2021. He has been the Managing Director of Camlin Fine Sciences Limited (formerly known as Camlin...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman & MD | no data | ₹28.22m | 10.34% ₹ 2.4b | |
| MD & Director | 4.9yrs | ₹24.56m | 1.88% ₹ 442.1m | |
| Executive Director of Technical & Executive Director | no data | ₹11.98m | 0.10% ₹ 23.9m | |
| Chief Financial Officer | 9.3yrs | データなし | データなし | |
| Chief Operating Officer | 2.4yrs | データなし | データなし | |
| Company Secretary | 4.5yrs | ₹1.39m | データなし | |
| Global Head of IT | no data | データなし | データなし | |
| Management Consultant | no data | データなし | データなし |
4.7yrs
平均在職期間
58.5yo
平均年齢
経験豊富な経営陣: 532834の経営陣は 経験豊富 であると考えられます ( 4.7年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman & MD | 19.3yrs | ₹28.22m | 10.34% ₹ 2.4b | |
| MD & Director | 11.8yrs | ₹24.56m | 1.88% ₹ 442.1m | |
| Executive Director of Technical & Executive Director | 7.9yrs | ₹11.98m | 0.10% ₹ 23.9m | |
| Independent Director | 1.3yrs | ₹600.00k | 0.068% ₹ 16.0m | |
| Non-Executive Non-Independent Director | 5.8yrs | データなし | データなし | |
| Non-Executive Independent Director | 4.6yrs | ₹2.45m | データなし | |
| Non-Executive Non-Independent Director | 8.6yrs | ₹700.00k | 1.57% ₹ 369.9m | |
| Independent Director | 5.7yrs | ₹2.46m | データなし | |
| Independent Non-Executive Director | 5.4yrs | ₹2.64m | 0.0031% ₹ 734.5k | |
| Independent Director | 6.8yrs | ₹2.18m | データなし | |
| Independent Director | 1.2yrs | ₹125.00k | データなし | |
| Non-Executive Non-Independent Director | 1.2yrs | データなし | データなし |
5.7yrs
平均在職期間
59.5yo
平均年齢
経験豊富なボード: 532834の 取締役会 は 経験豊富 であると考えられます ( 5.7年の平均在任期間)。
企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/05/22 15:15 |
| 終値 | 2026/05/22 00:00 |
| 収益 | 2025/12/31 |
| 年間収益 | 2025/03/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
Camlin Fine Sciences Limited 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。9
| アナリスト | 機関 |
|---|---|
| Ankur Periwal | Axis Capital Limited |
| Abhishek Navalgund | Centrum Broking Limited |
| Satish Kumar | CGS International |